Document is current
Any future updates will be listed below
-
Authors
Hoffman, Ann N.
Lam, Jamie
Hovda, David A.
Giza, Christopher C. https://orcid.org/0000-0002-5721-2667
Fanselow, Michael S.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (F32NS098694, R01NS27544)
UCLA Brain Injury Research Center, Joseph Drown Foundation, UCLA Steve Tisch BrainSPORT Program, Easton Labs for Brain Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH062122)
UCLA Depression Grand Challenge Fund, Staglin Center for Brain and Behavioral Health
- License Information
-
More Information
Article History
Received: 12 June 2019
Accepted: 10 September 2019
First Online: 25 September 2019
Competing Interests
: Disclosures unrelated to this project: A.N.H. and C.C.G. have received past research funding from Avanir Pharmaceuticals. M.S.F. is director of research for Neurovation Labs. C.C.G. receives consulting fees from NFL-Neurological Care Program, NHLPA, serves on the advisory panel for the Major League Soccer, NBA, NCAA, US Soccer Federation, California State Athletic Commission, Highmark International, and has received speaker fees from Medical Education Speakers Network and book royalties from Blackwell Publishing: Prioritized Neurological Differential Diagnosis.
